Nasdaq-listed BioNTech up 10% in pre-market trading, while vaccine development partner Pfizer is up >5%. Pfizer boss calls it “a great day for science and humanity”.
-
-
Show this thread
-
“This is an important step for science, the data showed that a vaccine can work," Ugur Sahin, co-founder and chief executive of BioNTech told the FT. “The likelihood that other vaccines are going to be also successful increased today”.
Show this thread -
Worth noting that several countries have already secured doses of the vaccine (which requires a booster shot).
200m doses, currently under negotiation
100m doses (with an option to acquire another 500m)
120m
30m
... among othersShow this thread -
BioNTech's boss told the FT the companies would “use a fair approach” when it came to distributing the first doses of the vaccine, adding that they would prioritise deliveries to countries where it had been approved for use. (Which looks like US and EU first).
Show this thread
End of conversation
New conversation -
-
-
Next challenge is to make people trust it
-
Genau!
End of conversation
New conversation -
-
-
@LorenzAdlung wollen wir uns mal die Paper dazu anschauen? Bin neugierig auf die Statistik usw -
This Tweet is unavailable.
- Show replies
New conversation -
-
-
Two things that should never rush in life science and sex



-
The French would put lunch before both

- Show replies
New conversation -
Loading seems to be taking a while.
Twitter may be over capacity or experiencing a momentary hiccup. Try again or visit Twitter Status for more information.
. Open DMs.